Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Blume, US
Aron Blume, Newton, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110286016 | METHOD AND APPARATUS FOR PRINTING IN A DISTRIBUTED COMMUNICATIONS NETWORK - A method and system is provided for printing jobs received from enterprise customers through a global printing network. One aspect relates to an architecture that interfaces customers, communication service firms (CSFs), and downstream digital print service providers (PSPs) in a global communications network. Such an architecture permits last-mile production functions that allow the distribution of print jobs to be optimized, containing costs, maintaining quality, and performing billing functions that improve the quality of such networks and make a global print network feasible. As a result, Enterprise customers benefit from lower costs and global sourcing while print service providers and graphics service firms benefit from increased revenue due to increased utilization of the overall global network. | 11-24-2011 |
Arthur J. Blume, Annandale, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090192072 | Insulin and IGF-1 Receptor Agonists and Antagonists - Peptide sequences capable of binding to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity and identified from various peptide libraries are disclosed. This invention also identifies at least two different binding sites, which are present on insulin and insulin-like growth factor receptors, and which selectively bind the peptides of this invention. As agonists, certain of the peptides of this invention may be useful for development as therapeutics to supplement or replace endogenous peptide hormones. The antagonists may also be developed as therapeutics. | 07-30-2009 |
| 20110124556 | Insulin and IGF-1 Receptor Agonists and Antagonists - Peptide sequences capable of binding to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity and identified from various peptide libraries are disclosed. This invention also identifies at least two different binding sites, which are present on insulin and insulin-like growth factor receptors, and which selectively bind the peptides of this invention. As agonists, certain of the peptides of this invention may be useful for development as therapeutics to supplement or replace endogenous peptide hormones. The antagonists may also be developed as therapeutics. | 05-26-2011 |
Arthur J. Blume, East Greenwich, RI US
| Patent application number | Description | Published |
|---|---|---|
| 20090053807 | Insulin and IGF-1 Receptor Agonists and Antagonists - Peptide sequences capable of binding to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity and identified from various peptide libraries are disclosed. This invention also identifies at least two different binding sites, which are present on insulin and insulin-like growth factor receptors, and which selectively bind the peptides of this invention. As agonists, the peptides of this invention may be useful for development as therapeutics to supplement or replace endogenous peptide hormones. The antagonist peptides may also be developed as therapeutics. | 02-26-2009 |
David M. Blume, Bonny Doon, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090105075 | Method for the use of distiller's grain as herbicide and fertilizer - A method of weed control using a biological paradigm. A method for the use of dried distiller's grain and soluble as an herbicide and a fertilizer in the use of crop production. A method for the processing of corn and other crops including the re-use of the dried grain by-products in subsequent crop production. A method for the production of grain alcohol including the re-use of the dried grain by-products in subsequent crop production. | 04-23-2009 |
Eric R. Blume, Seattle, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090314161 | Cyclone Separator - Systems and methods for separating contaminants in a contaminated airstream are described. In one embodiment, a contaminated airstream is received and a vortex is created that separates the contaminated airstream into a clean airstream used in the system and contaminants (e.g., debris and particles). | 12-24-2009 |
James G. Blume, Douglassville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100023435 | Balance Shared Payment Card - A payment card having account information associated therewith may include a substrate and a magnetic stripe adhered to a first side of the substrate. The magnetic stripe may be encoded with the account information. The account information may be associated with, for example, a non-profit organization that may be selected to receive a residual account balance of the payment card. | 01-28-2010 |
John E. Blume, Danville, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080318312 | PANCREATIC ISLET TRANSCRIPTION FACTOR AND USES THEREOF - The present invention provides a pancreatic islet transcription factor and methods of treating and diagnosing diabetes. | 12-25-2008 |
John E. Blume, Sunnyvale, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110166037 | Analysis of methylation using nucleic acid arrays - Arrays for genome-wide analysis of methylation are disclosed. IN a preferred aspect arrays comprising a plurality of probes complementary to a plurality of identified CpG islands in the human, mouse and rat genome are disclosed. The arrays may be used to detect methylation within cpG islands in samples from human, mouse and rat genomes. | 07-07-2011 |
John E. Blume, Bellingham, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20100184618 | DNA LIGATION ON RNA TEMPLATE - Disclosed are methods and compositions for detection and amplification of nucleic acids, wherein two DNA strands hybridized to an RNA strand are ligated. In one aspect, the disclosed methods include removal of an energy source, such as ATP, upon charging a ligase to form an enzyme-AMP intermediate, and then adding substrate, which results in one complete round of RNA-templated DNA ligation. In another aspect, the ligation reaction is accomplished by use of a mixture of at least two different ligase enzymes. The disclosed methods and compositions for RNA-templated DNA ligation may be particularly useful for detection of RNA sequence variants, for example RNA splice variants, and for quantitative expression analysis. | 07-22-2010 |
| 20110208500 | Methods and computer software for detecting splice variants - Methods and software products for analysis of alternative splicing are disclosed. In general the methods involve normalizing probe set or exon intensity to an expression level measurement of the gene. The methods may be used to identify tissue-specific alternative splicing events. | 08-25-2011 |
Kimberly M. Blume, Oviedo, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20120018616 | Optics for multi dimensional imaging - Optical systems and methods in accordance with some embodiments discussed herein can receive one or more beams of light from the system's field of view. Internal optical components can then direct the beam of light, including splitting the beam of light, rotating at least one of the split beams of light, and displacing one or more of the beams of light, such that the split beams of light are parallel to each other. Each beam of light may then be directed onto at least one linear detector array. The linear detector array can transform the light into electrical signals that can be processed and presented in a human-readable display. | 01-26-2012 |
Matthias Blume, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090319257 | TRANSLATION OF ENTITY NAMES - Methods and apparatus, including computer program products, related to entity name translation. In general, a set of data records including one or more names of one or more entities in a source language is received and candidate translations are generated for the names of the data records. The candidate translations are strings of characters in a target language that has a different orthography than an orthography of the source language. A data repository is queried for records matching the candidate translations. A translation of at least one of the candidate translations is selected based on a comparison of a combination of candidate translations and properties of the source record with the result of the querying the data repository. | 12-24-2009 |
Michael L. Blume US
| Patent application number | Description | Published |
|---|---|---|
| 20120018616 | Optics for multi dimensional imaging - Optical systems and methods in accordance with some embodiments discussed herein can receive one or more beams of light from the system's field of view. Internal optical components can then direct the beam of light, including splitting the beam of light, rotating at least one of the split beams of light, and displacing one or more of the beams of light, such that the split beams of light are parallel to each other. Each beam of light may then be directed onto at least one linear detector array. The linear detector array can transform the light into electrical signals that can be processed and presented in a human-readable display. | 01-26-2012 |
Ralph W. Blume, Fort Worth, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20110052689 | SUSTAINED RELEASE OF GUAIFENESIN - The invention relates to a novel pharmaceutical sustained release formulation of guaifenesin. The formulation may comprise a hydrophilic polymer, preferably a hydroxypropyl methylcellulose, and a water-insoluble polymer, preferably an acrylic resin, in a ratio range of about one-to-one (1: 1) to about nine-to-one (9: 1), more preferably a range of about three-to-two (3:2) to about six-to-one (6: 1), and most preferably in a range of about two-to-one (2: 1) to about four-to-one (4: 1) by weight. This formulation capable of providing therapeutically effective bioavailability of guaifenesin for at least twelve hours after dosing in a human subject. The invention also relates to a modified release product which has two portions: a first portion having an immediate release formulation of guaifenesin and a second portion having a sustained release formulation of guaifenesin. The modified release product has a maximum guaifenesin serum concentration equivalent to that of an immediate release guaifenesin tablet, and is capable of providing therapeutically effective bioavailability of guaifenesin for at least twelve hours after dosing in a human subject. | 03-03-2011 |
Richard Blume, Budd Lake, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20120009135 | PERSONAL CARE PRODUCT AND MANUFACTURE THEREOF - Disclosed is a package for a personal care composition, the package comprising a container containing a personal care composition, the container having a base comprising a base face for standing the package on a planar surface, and a cap removably connected to and covering a dispensing end of the container opposite to the base. The cap has an end face which is inclined to the base face, and the container and cap are shaped to permit the package, independent of the amount of the personal care composition contained within the container, selectively to be stood on the base face in an upright orientation on the planar surface or on the end face in an inverted orientation on the planar surface. | 01-12-2012 |
Todd Blume, Honolulu, HI US
| Patent application number | Description | Published |
|---|---|---|
| 20100268094 | Consumer electronic camera photoplethysmograph - A body part is placed on or near a consumer electronic device camera. The camera senses periodic light variations. A program analyses variations in images captured by the digital camera to determine pulse rate or breathing rate. | 10-21-2010 |
Walter M. Blume, St. Louis, MO US
| Patent application number | Description | Published |
|---|---|---|
| 20080228065 | System and Method for Registration of Localization and Imaging Systems for Navigational Control of Medical Devices - A system and method are provided for obtaining registration of a localization system's three-dimensional coordinates for a plurality of markers having known locations to the two-dimensional coordinates for the plurality of reference markers obtained from a single X-ray image. The method for registering a navigational system with a localization system having a plurality of reference markers includes determining the three-dimensional coordinates of the locations of a plurality of reference markers within the localization coordinate system, and providing a single two-dimensional X-ray image that includes a two dimensional location of the plurality of markers. The method further includes determining a coordinate transformation for obtaining a best fit registration of the localization system's three-dimensional coordinates to the two-dimensional coordinates obtained from the single X-ray image, for at least one reference marker location. | 09-18-2008 |
| 20080228068 | Automated Surgical Navigation with Electro-Anatomical and Pre-Operative Image Data - A method for navigating a medical device to an anatomical surface within a subject to perform electro-anatomical mapping using a magnetic navigation system is provided that includes importing a pre-operative image data set of an anatomical surface in the subject's body into a localization system. One or more control parameters are applied to the magnetic navigation system to drive the medical device to one or more points of tissue contact, from the locations of which a geometric anatomical map can be created and registered with the pre-operative anatomical image. The pre-operative anatomical surface image and a representation of the geometric anatomical map are displayed relative to one another, such that a user may select a location on the displayed pre-operative anatomical image to navigate the medical device towards. The localization system provides the location data to the magnetic navigation system to drive the medical device to the desired location, for enabling further electrophysiology mapping or ablation treatment. | 09-18-2008 |
| 20090177032 | METHOD AND APPARATUS FOR MAGNETICALLY CONTROLLING ENDOSCOPES IN BODY LUMENS AND CAVITIES - A magnetically navigable endoscope system includes an endoscope having a proximal end and a distal end, the distal end having a magnetic body; a component which transmits an image, associated with the distal end; a display component for displaying the image; a magnetic field generating apparatus for generating a magnetic field to orient the magnetic body and thus the distal end of the endoscope; and a controller coordinated with the display for controlling the magnetic field generating apparatus to selectively change the magnetic field to change the orientation of the magnetic body and thus the distal end of the endoscope. | 07-09-2009 |
| 20090177037 | REMOTE CONTROL OF MEDICAL DEVICES USING REAL TIME LOCATION DATA - A method of determining the quality of contact between a remotely navigated medical device and a cyclically moving anatomical structure includes measuring movement of the device, and processing the measured movement of the device to determine the contact between the device and the moving anatomical structure. | 07-09-2009 |
| 20100063385 | METHOD AND APPARATUS FOR MAGNETICALLY CONTROLLING CATHETERS IN BODY LUMENS AND CAVITIES - A method of navigating a magnet-tipped distal end of an elongate medical device through the body includes providing an image display of the part of the body through which the medical device is being navigated and using the display to input the desired path of the medical device by identifying points on the desired path on the display. The magnetic field needed to orient the end of the medical device in the direction of the desired path as indicated on the display is then determined. In one embodiment where only points on the desired path are identified, the field direction is the direction indicated by the points on the desired path. In a second embodiment, where points on the current path and the desired path are identified, the desired angle of deflection is determined, and the direction of the magnetic field is set to lead this desired angle of deflection by 90° to over-torque the end of the catheter, and the intensity of the field is determined from a table of experimentally determined field intensities for given angles of deflection. | 03-11-2010 |
| 20100097315 | GLOBAL INPUT DEVICE FOR MULTIPLE COMPUTER-CONTROLLED MEDICAL SYSTEMS - An integrated control and display system for operating a plurality of separate computer systems each having a visual display, includes at least one cursor control device for seamlessly moving a cursor among the visual displays of the separate computer systems, the cursor control device operating to control the computer system associated with the display on which the cursor appears. | 04-22-2010 |
| 20100174234 | METHOD AND APPARATUS FOR MAGNETICALLY CONTROLLING MOTION DIRECTION OF MECHANICALLY PUSHED CATHETER - The movement of a catheter through a medium, which may be living tissue such as a human brain, is controlled by mechanically pushing a flexible catheter having a magnetic tip through the medium and applying a magnetic field having a magnitude and a direction that guides the mechanically-pushed catheter tip stepwise along a desired path. The magnetic field is controlled in a Magnetic Stereotaxis System by a processor using an adaptation of a PID (proportional, integral, and derivative) feedback method. The magnetic fields are applied by superconducting coils, and the currents applied through the coils are selected to minimize a current metric. | 07-08-2010 |